News
PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...
Is long-acting HIV treatment as effective as daily pills? Early results say yes—with some risks of resistance in rare cases.
Human immunodeficiency virus, if untreated, causes acquired immunodeficiency syndrome (AIDS), and death. HIV is almost entirely preventable by using condoms, or by taking PrEP drugs. PrEP drugs do not ...
Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts say it's a much-needed, long-awaited tool — and they're pushing to make it ...
Georgia lawmakers are hoping to pass a bill before the legislative session ends Friday that would allow pharmacists to ...
There’s no cure yet for HIV or stage 3 HIV, also known as AIDS. However ... medications as prescribed, the drugs could stop working for them, and the virus could start multiplying.
Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load significantly.
Sub-Saharan Africa Leads Global HIV Decline Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS ... in the brain, drug may clear virus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results